praetego

Durham pharma lands $2.5M grant to advance its Alzheimer’s drug research

Posted by WRAL TechWire | Oct 8, 2022

Durham-based Praetego, a pharmaceutical company focused on treating neurodegenerative diseases related to aging, has received a $2.5 million grant from the National Institutes of Health to advance its lead drug candidate against Alzheimer’s disease.

Durham pharma company Praetego Inc wins $460,000 funding award from NIH

Posted by Jason Parker | Jun 18, 2021

A Durham-based pharma company will use new funding, awarded by the NIH, to extend preclinical investigation of a leading drug candidate that could prevent progression of neurodegeneration in Alzheimer’s Disease.